As a key regulator of ferroptosis, the inhibition of GPX4 makes drug-resistant tumor cells susceptible to ferroptosis, yet some tumor cells develop resistance mechanisms independent of ferroptosis (Shin et al., 2018). Here, GPX4 is linked to neoplasm.